公司资料
Palatin Technologies, Inc. 股价、新闻与催化剂
- 股票代码:
- PTN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
9.95 USD (+6.30%)
收盘价
最后更新: 2026年8月17日
24.7M USD
市值
股价为何变动
As of Aug 17, 2026, PTN closed up 6.30% at $9.95. No new same-company headline was identified in the current news window.
公司概览
业务概览
Palatin Technologies is a specialty pharmaceutical company focused on receptor biology and niche therapeutic areas. Its story has centered on a small set of programs and the difficulty of sustaining a durable commercial or development base.
所在地与行业分类
Palatin is headquartered in the United States and listed on NYSE American. It sits in specialty pharma rather than broad biotech.
商业模式特征
The company depends on clinical progress, commercial execution, and capital discipline. Investors typically watch pipeline updates and strategic positioning.
生物医药行业定位
Palatin occupies a small specialty-pharma niche within healthcare. It is a catalyst-sensitive story where a narrow set of programs can dominate the valuation.
未来催化剂
- Palatin’s catalysts are obesity and women’s-health programs, especially any development or partnering step that keeps the pipeline relevant. The company still needs a clearer path to value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。